Ingrid Øra

5.6k citations

81 papers · 2.6k indexed · h-index 28

Impact in

Neurology top 1%
- Neuroblastoma Research and Treatments
Cancer Research top 2%
- Cancer, Hypoxia, and Metabolism

Papers in ⓘ

Neurology 44
- Neuroblastoma Research and Treatments 43
Cancer Research 17
- Cancer, Hypoxia, and Metabolism 13

Co-authors: Sven Påhlman (11 shared papers)Rogier Versteeg (17 shared papers)Jan Köster (13 shared papers)Angelika Eggert (4 shared papers)David Gisselsson (21 shared papers)Håkan Axelson (5 shared papers)Lorenz Poellinger (2 shared papers)Helén Nilsson (2 shared papers)
Journals: International Journal of Cancer (6 papers)Genes Chromosomes and Cancer (6 papers)European Journal of Cancer (3 papers)Cancer Letters (3 papers)BMC Cancer (3 papers)
Partner nations: Sweden Netherlands United States

In The Last Decade

Ingrid Øra

79 papers receiving 2.6k citations

Peers

Countries citing papers authored by Ingrid Øra

Since Specialization

Citations

This map shows the geographic impact of Ingrid Øra's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ingrid Øra with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ingrid Øra more than expected).

Fields of papers citing papers by Ingrid Øra

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ingrid Øra. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ingrid Øra. The network helps show where Ingrid Øra may publish in the future.

Co-authors

The 25 scholars most cited alongside Ingrid Øra, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Ingrid Øra Line = papers co-authored together Ingrid Øra links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 81 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Lysine-Specific Demethylase 1 Is Strongly Expressed in Poorly Differentiated Neuroblastoma: Implications for Therapy Cancer Research ·Johannes H. Schulte, Soyoung Lim, Alexander Schramm, Nicolaus Friedrichs, Jan Köster, Rogier Versteeg, Ingrid Øra, Kristian W. Pajtler, Ludger Klein‐Hitpaß, Steffi Kuhfittig-Kulle, Eric Metzger, Roland Schüle, Angelika Eggert, Reinhard Buettner, Jutta Kirfel	2009	369
2	Hypoxia alters gene expression in human neuroblastoma cells toward an immature and neural crest-like phenotype Proceedings of the National Academy of Sciences ·Annika Jögi, Ingrid Øra, Helén Nilsson, Åsa Lindeheim, Yuichi Makino, Lorenz Poellinger, Håkan Axelson, Sven Påhlman	2002	314
3	NF1 Is a Tumor Suppressor in Neuroblastoma that Determines Retinoic Acid Response and Disease Outcome Cell ·Michael Hölzel, Sidong Huang, Jan Köster, Ingrid Øra, Arjan Lakeman, Huib N. Caron, Wouter Nijkamp, Jing Xie, Tom Callens, Shahab Asgharzadeh, Robert C. Seeger, Ludwine Messiaen, Rogier Versteeg, René Bernards	2010	144
4	A novel SERPINE1–FOSB fusion gene results in transcriptional up‐regulation of FOSB in pseudomyogenic haemangioendothelioma The Journal of Pathology ·Charles Walther, Johnbosco Tayebwa, Henrik Lilljebjörn, Linda Magnusson, Jenny Nilsson, Fredrik Vult von Steyern, Ingrid Øra, Henryk A. Domanski, Thoas Fioretos, Karolin H. Nord, Christopher D.�M. Fletcher, Fredrik Mertens	2013	141
5	High levels of HIF‐2α highlight an immature neural crest‐like neuroblastoma cell cohort located in a perivascular niche The Journal of Pathology ·Alexander Pietras, David Gisselsson, Ingrid Øra, Rosa Noguera, S Beckman, S. Navarro, Sven Påhlman	2008	87
6	A biology-driven approach identifies the hypoxia gene signature as a predictor of the outcome of neuroblastoma patients Molecular Cancer ·Paolo Fardin, Annalisa Barla, Sofia Mosci, Lorenzo Rosasco, Alessandro Verri, Rogier Versteeg, Huib N. Caron, Jan J. Molenaar, Ingrid Øra, Alessandra Eva, Maura Puppo, Luigi Varesio	2010	78
7	The MSX1 homeobox transcription factor is a downstream target of PHOX2B and activates the Delta–Notch pathway in neuroblastoma Experimental Cell Research ·Ingrid Revet, Gerda Huizenga, Alvin Chan, Jan Köster, Richard Volckmann, Peter van Sluis, Ingrid Øra, Rogier Versteeg, Dirk Geerts	2007	65
8	Neuroblastoma patient‐derived orthotopic xenografts retain metastatic patterns and geno‐ and phenotypes of patient tumours International Journal of Cancer ·Noémie Braekeveldt, Caroline Wigerup, David Gisselsson, Sofie Mohlin, My Merselius, Siv Beckman, Tord Jonson, Anna Börjesson, Torbjörn Backman, Irene Tadeo, Ana P. Berbegall, Ingrid Øra, Samuel Navarro, Rosa Noguera, Sven Påhlman, Daniel Bexell	2014	62
9	Progress in treatment and risk stratification of neuroblastoma: Impact on future clinical and basic research Seminars in Cancer Biology ·Ingrid Øra, Angelika Eggert	2011	61
10	Generation of trisomies in cancer cells by multipolar mitosis and incomplete cytokinesis Proceedings of the National Academy of Sciences ·David Gisselsson, Yuesheng Jin, David Lindgren, Persson Johan, Lennart Gisselsson, Sandra Hanks, Daniel Sehic, Linda Holmquist Mengelbier, Ingrid Øra, Nazneen Rahman, Fredrik Mertens, Felix Mitelman, Nils Mandahl	2010	61
11	Arsenic Trioxide Inhibits Neuroblastoma Growth in Vivo and Promotes Apoptotic Cell Death in Vitro Biochemical and Biophysical Research Communications ·Ingrid Øra, Lennart Bondesson, Carolin Jönsson, June Ljungberg, Isabella Pörn-Ares, Stanislaw Garwicz, Sven Påhlman	2000	57
12	Arsenic Trioxide-Induced Death of Neuroblastoma Cells Involves Activation of Bax and Does Not Require p53 Clinical Cancer Research ·Jenny Karlsson, Ingrid Øra, Isabella Pörn-Ares, Sven Påhlman	2004	55
13	Copy number defects of G1‐Cell cycle genes in neuroblastoma are frequent and correlate with high expression of E2F target genes and a poor prognosis Genes Chromosomes and Cancer ·Jan J. Molenaar, Jan Köster, Marli E. Ebus, Peter van Sluis, Ellen M. Westerhout, Katleen De Preter, David Gisselsson, Ingrid Øra, Frank Speleman, Huib N. Caron, Rogier Versteeg	2011	54
14	The basic helix-loop-helix transcription factor dHAND, a marker gene for the developing human sympathetic nervous system, is expressed in both high- and low-stage neuroblastomas. PubMed ·Carolina Gestblom, Anna Grynfeld, Ingrid Øra, Eva Örtoft, Christer Larsson, Håkan Axelson, Bengt Sandstedt, Peter Cserjesi, Eric N. Olson, Sven Påhlman	1999	53
15	Four evolutionary trajectories underlie genetic intratumoral variation in childhood cancer Nature Genetics ·Jenny Karlsson, Anders Valind, Linda Holmquist Mengelbier, Sofia Bredin, Louise Cornmark, Caroline Jansson, Amina Wali, Johan Staaf, Björn Viklund, Ingrid Øra, Anna Börjesson, Torbjörn Backman, Noémie Braekeveldt, Bengt Sandstedt, Niklas Pal, Anders Isaksson, Barbara Gürtl Lackner, Tord Jonson, Daniel Bexell, David Gisselsson	2018	46
16	Oncogenic activation of FOXR1 by 11q23 intrachromosomal deletion-fusions in neuroblastoma Oncogene ·E E Santo, M E Ebus, Jan Köster, Johannes H. Schulte, Arjan Lakeman, Peter van Sluis, Joëlle Vermeulen, David Gisselsson, Ingrid Øra, Scott Lindner, P G Buckley, R. L. Stallings, Jo Vandesompele, Angelika Eggert, HN Caron, Rogier Versteeg, J Jaap Molenaar	2011	45
17	Direct regulation of the minichromosome maintenance complex by MYCN in neuroblastoma European Journal of Cancer ·Arjen Koppen, Rachida Ait‐Aissa, Jan Köster, Peter G. van Sluis, Ingrid Øra, Huib N. Caron, Richard Volckmann, Rogier Versteeg, Linda J. Valentijn	2007	39
18	Hypoxia-induced dedifferentiation in neuroblastoma cells Cancer Letters ·Annika Jögi, Ingrid Øra, Helén Nilsson, Lorenz Poellinger, Håkan Axelson, Sven Påhlman	2003	39
19	Defective Chromosome Segregation and Telomere Dysfunction in Aggressive Wilms' Tumors Clinical Cancer Research ·Ylva Stewénius, Yuesheng Jin, Ingrid Øra, Jan de Kraker, Johannes Bras, Attila Frigyesi, J. Alumets, Bengt Sandstedt, Alan K. Meeker, David Gisselsson	2007	35
20	Targeted BCL2 inhibition effectively inhibits neuroblastoma tumour growth European Journal of Cancer ·Fieke Lamers, Linda Schild, Ilona J.M. den Hartog, Marli E. Ebus, Ellen M. Westerhout, Ingrid Øra, Jan Köster, Rogier Versteeg, Huib N. Caron, Jan J. Molenaar	2012	34

About Ingrid Øra

Ingrid Øra is a scholar working on Neurology, Cancer Research, Pediatrics, Perinatology and Child Health, Genetics and Hematology, having authored 81 papers that have together received 2.6k indexed citations. Recurring topics across this work include Neuroblastoma Research and Treatments (43 papers), Childhood Cancer Survivors' Quality of Life (14 papers), Cancer, Hypoxia, and Metabolism (13 papers), Acute Lymphoblastic Leukemia research (9 papers), Glioma Diagnosis and Treatment (8 papers), Virus-based gene therapy research (6 papers), Renal and related cancers (5 papers) and Sarcoma Diagnosis and Treatment (5 papers). The work is most often cited by research in Neurology (900 citations), Cancer Research (801 citations), Molecular Biology (1.5k citations), Oncology (537 citations) and Genetics (175 citations). Ingrid Øra has collaborated with scholars based in Sweden, Netherlands and United States. Frequent co-authors include Sven Påhlman, Rogier Versteeg, Jan Köster, Angelika Eggert, David Gisselsson, Håkan Axelson, Lorenz Poellinger, Helén Nilsson, Annika Jögi and Yuichi Makino. Their work appears in journals such as International Journal of Cancer, Genes Chromosomes and Cancer, European Journal of Cancer, Cancer Letters and BMC Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact